DV
DailyVial

Tirzepatide

well-studied
MounjaroZepboundGIP/GLP-1 dual agonist

A dual GIP/GLP-1 receptor agonist showing even greater weight loss results than semaglutide in clinical trials.

Category
weight loss
Dosage
2.5-15 mg/week (titrated up over 20+ weeks)
Half-Life
Approximately 5 days (120 hours)
Administration
Subcutaneous injection, once weekly

Overview

Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist developed by Eli Lilly. It works through two complementary pathways, which may explain its superior efficacy compared to GLP-1-only agonists.

The SURMOUNT clinical trials showed average weight loss of 20-25% of body weight — significantly more than semaglutide. Sold as Mounjaro (diabetes) and Zepbound (weight management). It represents the current frontier of pharmaceutical weight management.

VERIFIED SOURCE

Ready to Source Tirzepatide?

Get Tirzepatide from our top-rated supplier with COA verification and 20% first order + 10% lifetime commission.

Third-party testedCOA providedFast shipping
Shop Tirzepatide
from Ascension Peptides
Trusted by researchers•Secure checkout•Money-back guarantee

Benefits

  • ✓Superior weight loss vs semaglutide (20-25%)
  • ✓Dual mechanism of action
  • ✓Improved insulin sensitivity
  • ✓Significant HbA1c reduction
  • ✓Cardiovascular benefits
  • ✓Once-weekly dosing

Side Effects

  • ⚠Nausea (common during titration)
  • ⚠Diarrhea
  • ⚠Decreased appetite (intended effect)
  • ⚠Injection site reactions
  • ⚠Potential pancreatitis risk
  • ⚠Gallbladder issues

Research Guides

POPULAR
Buyer's Guide

Where to Buy Tirzepatide: Trusted Research Sources for 2026

Discover where to buy tirzepatide for research in 2026. Compare top vendors, pricing, purity standards, and quality verification for research-grade tirzepatide.

Supplier comparisons
Current pricing
Quality analysis
Compare Sources & Pricing →
Dosage Guide

Tirzepatide Dosage Guide for Weight Loss

Complete tirzepatide dosage guide for weight loss covering the 2.5 mg to 15 mg titration schedule. Evidence from SURMOUNT trials with administration guidance.

View Protocol →

Where to Source Tirzepatide

Quality and purity matter with peptides. Only buy from suppliers that provide third-party Certificate of Analysis (COA) testing. Compare verified sources below:

TOP CHOICE

Ascension Peptides

Third-party tested, US-based peptide supplier with COAs on every batch.

✓ COA Verified✓ US-Based✓ 3rd Party Tested
20% first order + 10% lifetime
Commission Rate
Free shipping $100+
Fast processing
Customer support
View Tirzepatide
View dosage guide →

Quick Comparison Guide

Quality
COA + 3rd party testing required
Purity
≥95% minimum standard
Storage
Lyophilized powder preferred
Shipping
Cold chain when needed

🔍 Buying Tips for Tirzepatide

  • • Always request Certificate of Analysis (COA) before purchasing
  • • Verify the supplier's testing methodology and third-party lab credentials
  • • Look for proper cold storage and shipping practices
  • • Start with smaller quantities to test supplier quality
  • • Join peptide communities for supplier reviews and experiences

Disclosure: DailyVial may earn a commission from qualifying purchases. This doesn't affect our editorial recommendations. See our affiliate disclosure for details.

Frequently Asked Questions

What is tirzepatide and how does it work?
Tirzepatide is a dual GIP/GLP-1 receptor agonist that targets two hormone pathways involved in blood sugar control and appetite regulation. This dual action makes it potentially more effective than single-target medications like semaglutide.
Is tirzepatide better than semaglutide for weight loss?
Clinical trials suggest tirzepatide may produce greater weight loss than semaglutide. The SURMOUNT trials showed average weight loss of 20-22% with tirzepatide versus 15-17% with semaglutide, though head-to-head comparisons are limited.
What are tirzepatide side effects?
Side effects are similar to other GLP-1 medications: nausea, vomiting, diarrhea, and decreased appetite. These are typically mild-to-moderate and improve over time. Serious but rare risks include pancreatitis and gallbladder issues.
How is tirzepatide dosed?
Tirzepatide is injected subcutaneously once weekly. Treatment starts at 2.5 mg weekly and increases every 4 weeks (5 mg, 7.5 mg, 10 mg, 12.5 mg, up to 15 mg) based on tolerance and weight loss response.
Is tirzepatide FDA approved?
Tirzepatide is FDA-approved as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management. It received approval for weight loss in November 2023.
What is the difference between tirzepatide and semaglutide?
The key difference is their mechanism: semaglutide targets only GLP-1 receptors, while tirzepatide is a dual agonist targeting both GIP and GLP-1 receptors. This dual action gives tirzepatide potentially greater efficacy — clinical trials showed 20-22% weight loss versus 15-17% with semaglutide. Tirzepatide may also have a more favorable side effect profile for some users.
How much weight can you lose on tirzepatide?
The SURMOUNT-1 trial showed participants lost an average of 22.5% of body weight at the highest dose (15 mg) over 72 weeks. At the 10 mg dose, average weight loss was about 20%. Some participants lost over 25% of their body weight, making tirzepatide the most effective weight loss medication studied to date.
What is the difference between Mounjaro and Zepbound?
Mounjaro and Zepbound both contain tirzepatide but are approved for different conditions. Mounjaro is approved for type 2 diabetes management, while Zepbound is specifically approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition. The dosing schedule is the same for both.
Can tirzepatide cause muscle loss?
Like all significant weight loss interventions, tirzepatide can lead to some lean muscle mass loss along with fat loss. Studies show roughly 25-40% of weight lost may come from lean mass. Resistance training and adequate protein intake (1.0-1.2 g/kg of body weight daily) during treatment are strongly recommended to preserve muscle mass.
How long do you stay on tirzepatide?
Tirzepatide is generally intended for long-term use. Clinical data shows that weight regain occurs after discontinuation, similar to semaglutide. Most healthcare providers recommend ongoing treatment for sustained results, though some patients transition to a lower maintenance dose after reaching their target weight.
Is tirzepatide covered by insurance?
Coverage depends on the indication and your insurance plan. Mounjaro (tirzepatide for diabetes) is covered by many insurance plans with prior authorization. Zepbound (tirzepatide for weight loss) has more limited coverage, as many insurers exclude weight loss medications. Manufacturer savings cards may reduce costs — Eli Lilly offers programs that can lower out-of-pocket costs significantly. Compounded tirzepatide is also available at lower cost through telehealth platforms.
What is tirzepatide face?
"Tirzepatide face" (also called "Ozempic face") refers to facial volume loss and sagging that can occur with rapid, significant weight loss from GLP-1 medications. As fat is lost from the face, it can create a gaunt or aged appearance. This is not unique to tirzepatide — it occurs with any rapid weight loss. Dermal fillers, maintaining adequate protein intake, and slower weight loss rates can help minimize this effect.
Can you drink alcohol on tirzepatide?
While alcohol is not strictly prohibited with tirzepatide, it is generally recommended to limit or avoid it. Alcohol can worsen GI side effects like nausea and vomiting, impair blood sugar regulation (especially in diabetic patients), and add empty calories that counteract weight loss goals. Additionally, tirzepatide slows gastric emptying, which may change how quickly alcohol is absorbed and metabolized.
Does tirzepatide cause pancreatitis?
Acute pancreatitis has been reported in clinical trials with tirzepatide, though it is rare. In the SURPASS and SURMOUNT trials, pancreatitis occurred in a small number of patients. Symptoms include severe abdominal pain radiating to the back, nausea, and vomiting. Tirzepatide should be discontinued if pancreatitis is suspected. Patients with a history of pancreatitis should discuss risks with their healthcare provider before starting treatment.
Can you switch from semaglutide to tirzepatide?
Yes, many patients switch from semaglutide to tirzepatide, often due to plateaued weight loss or seeking greater efficacy. The switch is typically done by starting tirzepatide at 2.5 mg/week and titrating up, regardless of prior semaglutide dose. Some physicians overlap the last semaglutide injection with the first tirzepatide injection, while others leave a one-week gap. Consult your prescriber for a personalized transition plan.
Does tirzepatide need to be refrigerated?
Unopened tirzepatide (Mounjaro/Zepbound) should be refrigerated at 2-8°C (36-46°F). Unopened pens can be stored at room temperature (up to 30°C/86°F) for up to 21 days if needed. Once in use, pens should be kept at room temperature and used within 21 days. Do not freeze tirzepatide, and protect it from direct heat and light.
What happens if you miss a dose of tirzepatide?
If you miss a dose, take it as soon as possible within 4 days (96 hours) of the missed dose. If more than 4 days have passed, skip the missed dose and take the next dose on the regularly scheduled day. Do not double up on doses. If multiple doses are missed, your healthcare provider may recommend restarting at a lower dose to minimize GI side effects.
Does tirzepatide affect fertility?
Tirzepatide is not recommended during pregnancy, and the FDA advises stopping it at least 1 month before attempting conception (due to its 5-day half-life). Some anecdotal reports suggest GLP-1 medications may improve fertility by addressing PCOS-related hormonal imbalances and improving insulin resistance, but clinical evidence is limited. Always discuss family planning with your healthcare provider when on tirzepatide.
Is tirzepatide available as a pill?
As of early 2026, tirzepatide is only available as a once-weekly subcutaneous injection (Mounjaro and Zepbound). Eli Lilly has been developing an oral formulation, with early clinical trials showing promising results. An oral version would likely improve patient compliance and accessibility, but it has not yet received FDA approval.

⚠ Research Disclaimer: This information is for educational purposes only and is not medical advice. Consult a qualified healthcare professional before using Tirzepatide or any peptide. See our full medical disclaimer.

Explore More Weight Loss Peptides

GLP-1 agonists and fat-burning peptides for sustainable weight management

View All Weight Loss Peptides →

Related Peptides

Semaglutide

A GLP-1 receptor agonist originally developed for type 2 diabetes, now the most prescribed weight loss medication worldwide.

AOD-9604

A modified fragment of human growth hormone specifically designed for fat burning without affecting blood sugar or growth.

Semaglutide

A GLP-1 receptor agonist originally developed for type 2 diabetes, now the most prescribed weight loss medication worldwide.

Research Guides

In-depth resources to help you source and use Tirzepatide effectively in research.

Buying Guide

Where to Buy Retatrutide in 2026 — Verified Sources & Pricing

Where to buy retatrutide in 2026. Top peptide vendors compared for purity, third-party testing, pricing, and shipping. Research-grade sources.

Read guide →
Buying Guide

Where to Buy Cagrilintide in 2026 — Trusted Peptide Sources

Where to buy cagrilintide in 2026. Compare research peptide vendors for purity, COAs, pricing, and fast shipping. Top verified sources.

Read guide →
Buying Guide

Semaglutide Cost in 2026 — Brand, Compounded & Research Pricing

Semaglutide cost breakdown for 2026. Compare brand Ozempic, compounded, and research peptide pricing. Learn how to save on semaglutide.

Read guide →
Buying Guide

Tirzepatide Cost in 2026 — Mounjaro, Compounded & Research Pricing

Tirzepatide cost guide for 2026. Compare Mounjaro pricing, compounded alternatives, and research peptide costs. Find the most affordable options.

Read guide →
Buying Guide

Semaglutide Compounding Pharmacy Guide — 503A, 503B & How to Choose

Find a legitimate semaglutide compounding pharmacy. Learn about 503A vs 503B facilities, quality checks, and how to verify your compounder.

Read guide →
Buying Guide

Tirzepatide Compounding Pharmacy — 503A vs 503B & How to Verify

Find a trustworthy tirzepatide compounding pharmacy. Understand 503A vs 503B differences, verification steps, and quality standards for compounded tirzepatide.

Read guide →
Buying Guide

How to Get Semaglutide in 2026 — Prescriptions, Telehealth & More

How to get semaglutide in 2026. Explore all pathways including prescriptions, telehealth, compounding pharmacies, and research vendors. Complete guide.

Read guide →
Buying Guide

How to Get Tirzepatide in 2026 — All Pathways From Rx to Research

How to get tirzepatide in 2026. Complete guide covering prescriptions, telehealth, compounding pharmacies, and research sources with pricing for each.

Read guide →
Buying Guide

Where to Buy Semaglutide Online in 2026: Trusted Sources & Guide

Find where to buy semaglutide online for research. Compare the best semaglutide sources, vendor reviews, pricing, and quality verification tips for 2026.

Read guide →
Buying Guide

Where to Buy Tirzepatide in 2026: Best Sources & Vendor Guide

Discover where to buy tirzepatide for research in 2026. Compare top vendors, pricing, purity standards, and quality verification for research-grade tirzepatide.

Read guide →
Dosage Guide

Semaglutide Microdosing: Low-Dose Protocols, Benefits & Risks (2026)

Is semaglutide microdosing effective for weight management? Learn about low-dose protocols, benefits, side effects, and what researchers are finding in 2026.

Read guide →
Dosage Guide

Semaglutide Dosage Guide for Weight Loss: Complete Protocol

Detailed semaglutide dosage guide for weight loss research. Covers titration schedules, weekly injection protocols, and dose escalation from 0.25 mg to 2.4 mg.

Read guide →
Dosage Guide

Tesamorelin Dosage Guide: FDA-Approved GHRH Protocol

Tesamorelin dosage guide covering the FDA-approved 2 mg daily protocol. Learn about injection timing, reconstitution, side effects, and clinical trial evidence.

Read guide →
Dosage Guide

AOD-9604 Dosage Guide: Fat Loss Peptide Protocol

AOD-9604 dosage guide with recommended doses for fat loss research. Covers the HGH fragment mechanism, injection timing, cycling, and clinical study evidence.

Read guide →
Dosage Guide

Retatrutide Dosage Guide: Triple Agonist Weight Loss Protocol

Retatrutide dosage guide covering this triple GIP/GLP-1/glucagon receptor agonist. Includes Phase 2 trial dosing data, titration, and administration protocols.

Read guide →
Dosage Guide

Cagrilintide Dosage Guide: Amylin Analog Weight Loss Protocol

Cagrilintide dosage guide covering this long-acting amylin analog for weight loss research. Includes Phase 2 trial dosing, titration schedules, and CagriSema.

Read guide →
Dosage Guide

Semaglutide Dosage Chart: Week-by-Week Titration Schedule

Visual semaglutide dosage chart with week-by-week titration from 0.25 mg to 2.4 mg. Includes injection volume calculations, pen compatibility, and dose.

Read guide →

Related Articles

Retatrutide: The Triple-Agonist Peptide That Could Change Weight Loss — 2026 Guide

Everything about retatrutide — the GLP-1/GIP/glucagon triple agonist showing 24% weight loss in trials. Mechanism, dosage, side effects, and how it compares to semaglutide and tirzepatide.

Semaglutide vs Tirzepatide: Which GLP-1 Peptide Is Right for You? (2026 Comparison)

Head-to-head comparison of semaglutide and tirzepatide for weight loss, diabetes management, and metabolic health. Research-backed analysis of efficacy, side.

How to Inject Semaglutide: Step-by-Step Injection Guide (2026)

Complete guide on how to inject semaglutide subcutaneously. Covers pen injectors, compounded vials, injection sites, timing, and tips to reduce nausea.